Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.

Hao Y, Chapuy B, Monti S, Sun HH, Rodig SJ, Shipp MA.

Clin Cancer Res. 2014 May 15;20(10):2674-83. doi: 10.1158/1078-0432.CCR-13-3007. Epub 2014 Mar 7.

2.

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F, Aguiar RC, Li S, Salles G, Berger F, Jing W, Pinkus GS, Habermann T, Dalla-Favera R, Harris NL, Aster JC, Golub TR, Shipp MA.

Blood. 2003 Dec 1;102(12):3871-9. Epub 2003 Aug 21.

PMID:
12933571

Supplemental Content

Loading ...
Support Center